Novartis C.E.O. Defends Company’s Decision to Withhold False Data From the F.D.A.
By KATIE THOMAS from NYT Health https://ift.tt/2YPZ7N5
via
Novartis C.E.O. Defends Company’s Decision to Withhold False Data From the F.D.A.
![Novartis C.E.O. Defends Company’s Decision to Withhold False Data From the F.D.A.]()
Reviewed by news100
on
11:19 AM
Rating:
No comments